Philab Holdings Corp. (DNA), formerly Alterra Capital Partners, Inc. (ALT), was registered with the Securities and Exchange Commission (SEC) on February 28, 1980. DNA's primary purpose is to manufacture, sell, and import all classes of scientific, medical, education, electronics, laboratory, research, testing and measuring machineries, equipment, apparatus, furniture and fixture. <br/><br/>Previously, ALT was engaged in the development of software solutions as well as the trading of computer hardware and software products. In December 2016, ALT acquired 93.48% of the total outstanding capital stock of DNA. The SEC approved the change in corporate name to the present one on January 20, 2017.<br/><br/>On January 17, 2017, DNA filed with the SEC the registration statement in relation to its follow-on offering (FOO) of up to 500 million common shares. Philippine Commercial Capital, Inc. is the lead underwriter for the FOO.<br/><br/>Source: SEC Form 17-A (2015)/Disc. Nos. 7100-2016/0261/0395/0695-2017